Search Results

productive lab—it accelerated outcomes and laid the cultural foundation for the next generation of biotech insights from major conferences, emerging research, and expert commentary Whether you’re a pharmacologist, biotech

Industry insights:  Metabolic GPCRs in the spotlight; receptor motion tracking tools; obesity treatment race Stop wasting talent:  When senior leaders spend nights copy-pasting data, your burn rate accelerates GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

Explore this week’s research, tools, and biotech insights in one place.

Industry News Domain Therapeutics was one of the 4 Biotech Trophy nominees at 2023 HealthTech awards. The delisting dilemma: Why do so many biotechs face being kicked off the Nasdaq?. (April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) SLAS Europe 2023 Conference and Exhibition

I've seen this pattern unfold across biotech, academia, and nonprofits. Traditional roles rarely gave me the freedom to implement these changes at the scale needed.

Explore this week’s research, tools, and biotech insights in one place. The insights are ready.

with your topic suggestions 🆕 Weekly new releases to stay ahead of the science 🧠 Content built for biotech Rare-earth europium complexes offered potential—but the chemistry was brutal. Because they give researchers something rare in CNS work: clarity in complexity. GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

About Celtarys Research Celtarys Research is a biotech company based in Spain that specializes in the

Industry News Biotech startup Structure pulls off rare IPO, raising $161M 3-drug combo leads to 'unprecedented Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) arcoscreen is one of the 13 biotech

The Boston biotech revealed Wednesday afternoon that it would downsize its research to focus on its lead

Industry News InterAx Biotech to Apply its Leading AI and Cell Signalling Technology to Support Target Validation for a Sosei Heptares GPCR Discovery Program Salipro Biotech and DyNAbind Announce Milestone Clinical Stage X4 Pharmaceuticals Announces Positive Phase 3 Results Showing Mavorixafor Reduced the Rate

pathway of opioid drugs into cellular structures Inversago Pharma will present at BBHIC 2023 Orion Biotechnology attended the Swiss Biotech Day Addex Therapeutics attended the Swiss Biotech Day Sosei Heptares presented

Plus: must-read chemokine and PTH1R papers, and new momentum across biotech—from Superluminal to Neurocrine

January 2022 "G-protein-coupled receptors’ star has been on the rise in biotech in recent years as researchers

fruitful research space has led to more than 700 approved drugs over previous decades—but the two-year-old biotech

That money has gone to some 60 biotechs, much of it as early funding."

In Episode 3 of 3  of our series with Celtarys Research , leaders from academia and biotech unpack what A quick rating on Spotify or Apple Podcasts — and a YouTube subscribe — helps us reach more scientists GPCR Premium Member And Lock in The Current Rate➤ https://www.ecosystem.drgpcr.com/gpcr-university-pricing

(“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, announced

Joanne Waldstreicher to its Board of Directors GPCR Therapeutics launches multiple myeloma trial Salipro Biotech organized by LINK-J Jounce takes the cash under amended deal with Gilead on anti-CCR8 antibody InterAx Biotech

Inês Pinheiro and Oliver Hartley from the Orion Biotechnology team on their recent study on Arylsulfatases Enter Agreement for Rhythm to Acquire Global Rights to Oral MC4R Agonist LB54640 Addex to Present at Biotech Conference Isomorphic Labs Announces Strategic Multi-Target Research Collaboration With Novartis Salipro Biotech

Our partner, Domain Therapeutics, will attend the SACHS 23rd annual biotech event in Europe. Dr. Therapeutics CEO Pascal Neuville to Discuss Game-Changing GPCR-Targeting Immunotherapies at Sachs Associates' Biotech

If you’re in GPCR discovery or biotech R&D, this is a masterclass in turning deep science into scalable David Parker spent years designing rare-earth europium probes. Partnerships, Not Just Sponsorships Behind every breakthrough assay is a web of collaborations that rarely

Anyone who joins before the change is fully grandfathered  — your rate stays locked, and your whole team GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

When a compound’s off-rate is slower than its clearance, its biological effect outlives its plasma presence The on-rate/off-rate balance  matters: too tight, and penetration stalls; too loose, and efficacy dissipates The metrics shift: k_inact  (rate of inactivation) replaces static Ki values. k_inact/KI  becomes the Kenakin Content trusted by biotech, pharma, and academia 💎 $2999/year — one conference cost = a full

GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

When crystal structures were finally solved, the models aligned strikingly well—a rare and powerful validation Translational Impact for Drug Discovery While the Carlsson lab is rooted in academia, its impact extends into biotech

Submit a logo design by Nov 1st on the Logo Contest page. Chris Cargill Wins Executive of the Year at the Citeline Pharma Intelligence Awards Japan 2023 Salipro Biotech

unanswered questions about blockbuster weight-loss drugs Transforming Drug Discovery: Insights from Viva Biotech's

Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights Salipro Biotech (April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) SLAS Europe 2023 Conference and Exhibition

prestigious international award – exemplified by the fact that other winners this year are the co-founders of BioNTech